» Articles » PMID: 37553811

Hijacking Homeostasis: Regulation of the Tumor Microenvironment by Apoptosis

Overview
Journal Immunol Rev
Date 2023 Aug 9
PMID 37553811
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers are genetically driven, rogue tissues which generate dysfunctional, obdurate organs by hijacking normal, homeostatic programs. Apoptosis is an evolutionarily conserved regulated cell death program and a profoundly important homeostatic mechanism that is common (alongside tumor cell proliferation) in actively growing cancers, as well as in tumors responding to cytotoxic anti-cancer therapies. Although well known for its cell-autonomous tumor-suppressive qualities, apoptosis harbors pro-oncogenic properties which are deployed through non-cell-autonomous mechanisms and which generally remain poorly defined. Here, the roles of apoptosis in tumor biology are reviewed, with particular focus on the secreted and fragmentation products of apoptotic tumor cells and their effects on tumor-associated macrophages, key supportive cells in the aberrant homeostasis of the tumor microenvironment. Historical aspects of cell loss in tumor growth kinetics are considered and the impact (and potential impact) on tumor growth of apoptotic-cell clearance (efferocytosis) as well as released soluble and extracellular vesicle-associated factors are discussed from the perspectives of inflammation, tissue repair, and regeneration programs. An "apoptosis-centric" view is proposed in which dying tumor cells provide an important platform for intricate intercellular communication networks in growing cancers. The perspective has implications for future research and for improving cancer diagnosis and therapy.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.


C-reactive protein-induced injury in -infected lung epithelial cells is mediated by the P38 MAPK/mitochondrial apoptosis pathway.

Li L, Zhang Y, Zhao L, Shi Y Microbiol Spectr. 2025; 13(3):e0162624.

PMID: 39932324 PMC: 11878036. DOI: 10.1128/spectrum.01626-24.


Long non-coding RNAs are involved in the crosstalk between cancer-associated fibroblasts and tumor cells.

Yang C, Shu J, Li Y, Zhao N, Liu X, Tian X Front Immunol. 2024; 15:1469918.

PMID: 39717771 PMC: 11663902. DOI: 10.3389/fimmu.2024.1469918.


Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response.

Shahrouzi P, Azimzade Y, Brankiewicz-Kopcinska W, Bhatia S, Kunke D, Richard D Breast Cancer Res. 2024; 26(1):170.

PMID: 39605038 PMC: 11600738. DOI: 10.1186/s13058-024-01924-4.


Mechanism of Efferocytosis in Determining Ischaemic Stroke Resolution-Diving into Microglia/Macrophage Functions and Therapeutic Modality.

Xie X, Dong S, Liu R, Shi L, Zhu T Mol Neurobiol. 2024; 61(10):7583-7602.

PMID: 38409642 DOI: 10.1007/s12035-024-04060-4.


References
1.
Akalu Y, Rothlin C, Ghosh S . TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy. Immunol Rev. 2017; 276(1):165-177. PMC: 5381815. DOI: 10.1111/imr.12522. View

2.
Truman L, Ford C, Pasikowska M, Pound J, Wilkinson S, Dumitriu I . CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008; 112(13):5026-36. DOI: 10.1182/blood-2008-06-162404. View

3.
Elliott M, Ravichandran K . The Dynamics of Apoptotic Cell Clearance. Dev Cell. 2016; 38(2):147-60. PMC: 4966906. DOI: 10.1016/j.devcel.2016.06.029. View

4.
Medina C, Mehrotra P, Arandjelovic S, Perry J, Guo Y, Morioka S . Metabolites released from apoptotic cells act as tissue messengers. Nature. 2020; 580(7801):130-135. PMC: 7217709. DOI: 10.1038/s41586-020-2121-3. View

5.
Billman G . Homeostasis: The Underappreciated and Far Too Often Ignored Central Organizing Principle of Physiology. Front Physiol. 2020; 11:200. PMC: 7076167. DOI: 10.3389/fphys.2020.00200. View